Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Treasury Shares: 2023-2024

Historic Treasury Shares for Avidity Biosciences (RNA) over the last 2 years, with Dec 2024 value amounting to $2.1 million.

  • Avidity Biosciences' Treasury Shares rose 85.87% to $2.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.6 million, marking a year-over-year increase of 85.87%. This contributed to the annual value of $2.1 million for FY2024, which is 178.50% up from last year.
  • As of FY2024, Avidity Biosciences' Treasury Shares stood at $2.1 million, which was up 178.50% from $758,000 recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Treasury Shares registered a high of $2.1 million during FY2024, and its lowest value of $758,000 during FY2023.
  • In the last 2 years, Avidity Biosciences' Treasury Shares had a median value of $1.4 million in 2023 and averaged $1.4 million.
  • Data for Avidity Biosciences' Treasury Shares shows a peak YoY spiked of 178.50% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Avidity Biosciences' Treasury Shares stood at $758,000 in 2023, then spiked by 178.50% to $2.1 million in 2024.